Published in Postgrad Med J on January 01, 1981
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J (1985) 2.92
Pre-hospital opiate and aspirin administration in patients with suspected myocardial infarction. BMJ (1994) 2.46
Treatment of atrial fibrillation in a district general hospital. Br Heart J (1994) 2.40
ABC of palliative care. Non-malignant conditions. BMJ (1998) 2.24
Cardiac troponin T. Lancet (1993) 2.13
Secondary harmonic imaging overestimates left ventricular mass compared to fundamental echocardiography. Eur J Echocardiogr (2003) 2.11
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Clin Pharmacol Ther (1999) 2.06
Use of fax facility improves decision making regarding thrombolysis in acute myocardial infarction. Heart (1997) 2.01
Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma. Ann Clin Biochem (1991) 1.91
Receptor-mediated low density lipoprotein catabolism in man. J Lipid Res (1979) 1.88
Leg-vein thrombosis following myocardial infarction. Lancet (1970) 1.85
The genetic determination of left ventricular mass in healthy adults. Eur Heart J (2003) 1.77
Management of paroxysmal atrial fibrillation. Q J Med (1993) 1.75
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J (1988) 1.75
Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects. Eur J Clin Pharmacol (1983) 1.73
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J (1989) 1.70
A general practitioner electrocardiogram service. Scott Med J (1967) 1.69
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J (1999) 1.64
Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J (1996) 1.63
Direct admission to the coronary care unit by the ambulance service for patients with suspected myocardial infarction. Heart (1997) 1.60
Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. Am Heart J (1996) 1.59
Early treatment of myocardial infarction in the community. Br Med J (1978) 1.58
3 and 12 lead electrocardiogram interpretation by computer. A comparison on 1093 patients. Br Heart J (1971) 1.56
Blood pressure in a Scottish island community. Br Med J (1969) 1.50
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation (1997) 1.47
A survey of nuclear cardiological practice in Great Britain. The British Nuclear Cardiology Group. Br Heart J (1992) 1.45
Blood pressure and catecholamine responses to 'stress' in normotensive and hypertensive subjects. Cardiovasc Res (1971) 1.43
Relation between extent of coronary artery disease and blood viscosity. Br Med J (1980) 1.42
Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br J Anaesth (1988) 1.41
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J (1995) 1.38
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Cardiology: the development of a managed clinical network. BMJ (2000) 1.34
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest (1984) 1.29
Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation (1993) 1.26
Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG. Br Heart J (1992) 1.22
Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction. Lancet (1990) 1.20
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients. Metabolism (1976) 1.12
A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J (1980) 1.11
Ultrafiltration in the management of refractory congestive heart failure. Br Heart J (1986) 1.11
The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Eur Heart J (1985) 1.11
Relation between extent of coronary artery disease and severity of hyperlipoproteinaemia. Br Heart J (1975) 1.10
Wide variation in the use of thrombolytic therapy among junior doctors in south and central Scotland. Health Bull (Edinb) (1996) 1.09
Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction. Thromb Haemost (1984) 1.08
Beta blockers and verapamil: a cautionary tale. Br Med J (Clin Res Ed) (1984) 1.08
Leucocyte ascorbic acid levels after acute myocardial infarction. Br Heart J (1972) 1.08
Heart rate variability in left ventricular hypertrophy. Br Heart J (1995) 1.07
Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic. J Hypertens (1990) 1.07
Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J (1980) 1.07
Diagnosis and treatment of digoxin toxicity. Postgrad Med J (1993) 1.06
Acceleration of ventricular response to atrial flutter after intravenous adenosine. Br Heart J (1993) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol (1992) 1.06
Leaking false aneurysm of right coronary saphenous vein graft; successful treatment by percutaneous coil embolisation. Br Heart J (1992) 1.02
Evaluation of thallium-201 exercise scintigraphy in coronary heart disease. Br Heart J (1979) 1.01
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Am J Cardiol (1985) 1.00
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension. Gut (1984) 1.00
Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med (1983) 1.00
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
ABC of sports medicine. Sudden death in sport. BMJ (1994) 0.99
Alcoholic ketoacidosis: a case report. Scott Med J (1987) 0.99
Malignant hypertension associated with use of oral contraceptives. Br Heart J (1975) 0.98
Familial pattern of corticosteroids and their metabolism in adult human subjects--the Scottish Adult Twin Study. J Clin Endocrinol Metab (1999) 0.98
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol (1983) 0.97
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol (1984) 0.97
Questionnaire survey of thrombolytic treatment in accident and emergency departments in the United Kingdom. BMJ (1998) 0.97
Comparison of enalapril and atenolol in mild to moderate hypertension. Am J Med (1989) 0.96
Intracoronary thrombolytic therapy performed within a coronary care unit: one year's experience. Scott Med J (1986) 0.96
Prevalence of hyperlipoproteinaemia in apparently healthy men. Br Heart J (1974) 0.96
Serial measurements of left ventricular dimensions by echocardiography. Assessment of week-to-week, inter- and intraobserver variability in normal subjects and patients with valvular heart disease. Br Heart J (1980) 0.96
Exercise prescription in adults with congenital heart disease: a long way to go. Heart (2000) 0.96
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Relation between prognosis and the blood pressure before and during treatment of hypertensive patients. Clin Sci Mol Med Suppl (1978) 0.95
Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension. J Hypertens (1992) 0.94
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart (2006) 0.94